ExodusPoint Capital Management’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.08M | Buy |
320,217
+296,480
| +1,249% | +$1.93M | 0.02% | 679 |
|
|
2025
Q1 | $188K | Sell |
23,737
-191,400
| -89% | -$1.52M | ﹤0.01% | 1247 |
|
|
2024
Q4 | $2.73M | Buy |
+215,137
| New | +$2.73M | 0.02% | 558 |
|
|
2024
Q3 | – | Sell |
-14,873
| Closed | -$205K | – | 1579 |
|
|
2024
Q2 | $205K | Sell |
14,873
-82,748
| -85% | -$1.14M | ﹤0.01% | 1260 |
|
|
2024
Q1 | $1.61M | Buy |
97,621
+56,718
| +139% | +$937K | 0.01% | 685 |
|
|
2023
Q4 | $597K | Sell |
40,903
-183,706
| -82% | -$2.68M | ﹤0.01% | 912 |
|
|
2023
Q3 | $2.76M | Buy |
224,609
+37,424
| +20% | +$459K | 0.03% | 535 |
|
|
2023
Q2 | $2.24M | Buy |
+187,185
| New | +$2.24M | 0.02% | 687 |
|
|
2023
Q1 | – | Sell |
-65,929
| Closed | -$1.42M | – | 1717 |
|
|
2022
Q4 | $1.42M | Buy |
65,929
+53,026
| +411% | +$1.14M | 0.02% | 771 |
|
|
2022
Q3 | $258K | Sell |
12,903
-10,100
| -44% | -$202K | ﹤0.01% | 1531 |
|
|
2022
Q2 | $412K | Buy |
+23,003
| New | +$412K | 0.01% | 1381 |
|
|
2021
Q3 | – | Sell |
-9,372
| Closed | -$213K | – | 2152 |
|
|
2021
Q2 | $213K | Buy |
+9,372
| New | +$213K | ﹤0.01% | 1873 |
|